ArticleJournal of controlled release : official journal of the Controlled Release Society2016

Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.

Szu-Ting Chou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.